[Evaluation of combined treatment in stage-II cervical cancer in terms of morphologic structure of the tumor].
The efficacy of stage II cervical cancer (CC) treatment was evaluated in two groups: squamous cell carcinoma--151, cervical adenocarcinoma (CAC)--49. All the patients received combined treatment (preoperative large-fraction brachytherapy + surgery + postoperative radiation). A comparison of the results highlighted the role of morphological pattern of tumor as a factor of cure. Five-year survival rates for CAC stage II patients were lower by 12.4% while the incidence of distant lymphogenous metastases and those to organs, responsible for failed therapy, was 2.7 times as high.
Vishnevskaia
E E
EE
N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
Okeanova
N I
NI
Shelkovich
S E
SE
Matylevich
O P
OP
D000230:Adenocarcinoma / Q000473:pathology / Q000532:radiotherapy; D000328:Adult; D000368:Aged; D001918:Brachytherapy; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000532:radiotherapy; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008875:Middle Aged; D020360:Neoadjuvant Therapy; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D016019:Survival Analysis; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000150:complications / Q000401:mortality / Q000473:pathology* / Q000532:radiotherapy* / Q000601:surgery